Unlocking the Future of Immunotherapy

At Valora Therapeutics, we are not just developing therapies; we aim to restore the defective language of immune communication in disease. Our proprietary AbLec™ platform decodes the complex sugar code of cellular to immune interactions, unlocking new possibilities in immunotherapy.

We embrace bold innovation and scientific curiosity as we navigate the path ahead, advancing our understanding of glycobiology and its therapeutic potential.

We are driven by possibilities of making a meaningful difference in patients' lives.